Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.

about

Trastuzumab and survival of patients with metastatic breast cancer.

P2860

Q40159320-C66A8031-0B03-42FF-A60D-8585E7E55799

P2860

Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.

Item

http://www.wikidata.org/entity/Q35829230

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinicopathologic characterist ...... east cancer in southern China.

@ast

Clinicopathologic characterist ...... east cancer in southern China.

@en

type

Item

label

Clinicopathologic characterist ...... east cancer in southern China.

@ast

Clinicopathologic characterist ...... east cancer in southern China.

@en

prefLabel

Clinicopathologic characterist ...... east cancer in southern China.

@ast

Clinicopathologic characterist ...... east cancer in southern China.

@en

P1476

Clinicopathologic characterist ...... east cancer in southern China.

@en

P2093

Bing Bai

http://www.w3.org/2001/XMLSchema#string

Dong-Geng Liu

http://www.w3.org/2001/XMLSchema#string

Rou-Jun Peng

http://www.w3.org/2001/XMLSchema#string

Shu-Sen Wang

http://www.w3.org/2001/XMLSchema#string

Tao Qin

http://www.w3.org/2001/XMLSchema#string

Xiao-Yu Teng

http://www.w3.org/2001/XMLSchema#string

Yan-Xia Shi

http://www.w3.org/2001/XMLSchema#string

Yin-Duo Zeng

http://www.w3.org/2001/XMLSchema#string

Zhong-Yu Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry.

Breast cancer in Hong Kong, Southern China: the first population-based analysis of epidemiological characteristics, stage-specific, cancer-specific, and disease-free survival in breast cancer patients: 1997-2001.

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.

P304

544-550

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/AOMS.2015.52356

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280124341

http://www.w3.org/2001/XMLSchema#string

P698

26170847

http://www.w3.org/2001/XMLSchema#string

P932

4495150

http://www.w3.org/2001/XMLSchema#string

Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.

about

P2860

P2860

Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932